Trauma-focused EMDR for Personality disorders among Outpatients (TEMPO): study protocol for a multi-centre, single-blind, randomized controlled trial
Gespeichert in:
| Titel: | Trauma-focused EMDR for Personality disorders among Outpatients (TEMPO): study protocol for a multi-centre, single-blind, randomized controlled trial |
|---|---|
| Autoren: | Hofman, Simon, Hafkemeijer, Laurian, de Jongh, Ad, Starrenburg, Annemieke, Slotema, Karin |
| Quelle: | Hofman, S, Hafkemeijer, L, de Jongh, A, Starrenburg, A & Slotema, K 2022, 'Trauma-focused EMDR for Personality disorders among Outpatients (TEMPO): study protocol for a multi-centre, single-blind, randomized controlled trial', Trials, vol. 23, 196. https://doi.org/10.1186/s13063-022-06082-6 |
| Publikationsjahr: | 2022 |
| Bestand: | Queen's University Belfast: Research Portal |
| Schlagwörter: | Effectiveness, Predictors, Multicenter Studies as Topic, Economic evaluation, Single-Blind Method, Stress Disorders, Post-Traumatic - diagnosis - psychology - therapy, Humans, Trauma, Cyclic N-Oxides, EMDR, Eye Movement Desensitization Reprocessing - methods, Cost-effectiveness, Treatment Outcome, Personality Disorders - diagnosis - therapy, Personality disorder, Randomized controlled trial, Treatment experiences, Outpatients, Study protocol, Quality of Life, Randomized Controlled Trials as Topic, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being |
| Beschreibung: | Background Existing recommended treatment options for personality disorders (PDs) are extensive and costly. There is emerging evidence indicating that trauma-focused treatment using eye movement desensitization and reprocessing (EMDR) therapy aimed at resolving memories of individuals’ adverse events can be beneficial for this target group within a relatively short time frame. The primary purpose of the present study is to determine the effectiveness of EMDR therapy versus waiting list in reducing PD symptom severity. Furthermore, the effects of EMDR therapy on trauma symptom severity, loss of diagnosis, personal functioning, quality of life, and mental health outcomes will be determined. In addition, the cost-effectiveness of EMDR therapy in the treatment of PDs is investigated. Moreover, predictors of treatment success, symptom deterioration and treatment discontinuation will be assessed. Lastly, experiences with EMDR therapy will be explored. Method In total, 159 patients with a PD will be included in a large multicentre single-blind randomized controlled trial. The Structured Clinical Interview for DSM-5 Personality Disorders will be used to determine the presence of a PD. Participants will be allocated to either a treatment condition with EMDR therapy (ten biweekly 90-min sessions) or a waiting list. Three months after potential treatment with EMDR therapy, patients can receive treatment as usual for their PD. All participants are subject to single-blinded baseline, post-intervention and 3-, 6- and 12-month follow-up assessments. The primary outcome measures are the Assessment of DSM-IV Personality Disorders and the Clinician-Administered PTSD Scale for DSM-5. For cost-effectiveness, the Treatment Inventory of Costs in Patients with psychiatric disorders, EuroQol-5D-3L, and the Mental Health Quality of Life Questionnaire will be administered. The PTSD Checklist for DSM-5, Brief State Paranoia Checklist and Difficulties in Emotion Regulation Scale will be used to further index trauma symptom severity. Type ... |
| Publikationsart: | article in journal/newspaper |
| Dateibeschreibung: | application/pdf |
| Sprache: | English |
| DOI: | 10.1186/s13063-022-06082-6 |
| Verfügbarkeit: | https://pure.qub.ac.uk/en/publications/2127ae98-7c20-4507-8eaf-c6c79817287f https://doi.org/10.1186/s13063-022-06082-6 https://pureadmin.qub.ac.uk/ws/files/299492017/s13063_022_06082_6.pdf |
| Rights: | info:eu-repo/semantics/openAccess |
| Dokumentencode: | edsbas.200E8EB2 |
| Datenbank: | BASE |
Nájsť tento článok vo Web of Science | Abstract: | Background Existing recommended treatment options for personality disorders (PDs) are extensive and costly. There is emerging evidence indicating that trauma-focused treatment using eye movement desensitization and reprocessing (EMDR) therapy aimed at resolving memories of individuals’ adverse events can be beneficial for this target group within a relatively short time frame. The primary purpose of the present study is to determine the effectiveness of EMDR therapy versus waiting list in reducing PD symptom severity. Furthermore, the effects of EMDR therapy on trauma symptom severity, loss of diagnosis, personal functioning, quality of life, and mental health outcomes will be determined. In addition, the cost-effectiveness of EMDR therapy in the treatment of PDs is investigated. Moreover, predictors of treatment success, symptom deterioration and treatment discontinuation will be assessed. Lastly, experiences with EMDR therapy will be explored. Method In total, 159 patients with a PD will be included in a large multicentre single-blind randomized controlled trial. The Structured Clinical Interview for DSM-5 Personality Disorders will be used to determine the presence of a PD. Participants will be allocated to either a treatment condition with EMDR therapy (ten biweekly 90-min sessions) or a waiting list. Three months after potential treatment with EMDR therapy, patients can receive treatment as usual for their PD. All participants are subject to single-blinded baseline, post-intervention and 3-, 6- and 12-month follow-up assessments. The primary outcome measures are the Assessment of DSM-IV Personality Disorders and the Clinician-Administered PTSD Scale for DSM-5. For cost-effectiveness, the Treatment Inventory of Costs in Patients with psychiatric disorders, EuroQol-5D-3L, and the Mental Health Quality of Life Questionnaire will be administered. The PTSD Checklist for DSM-5, Brief State Paranoia Checklist and Difficulties in Emotion Regulation Scale will be used to further index trauma symptom severity. Type ... |
|---|---|
| DOI: | 10.1186/s13063-022-06082-6 |